以岭药业的经营和成就-极坐标图-数据可视化

以岭药业(002603),全称石家庄以岭药业股份有限公司(Shijiazhuang Yiling Pharmaceutical Co., Ltd.),主营业务为中成药的研发、生产和销售。,位于河北石家庄市,董事长为吴相君,总经理为吴相君。网址为www.yiling.cn。

《以岭药业的经营和成就》石家庄以岭药业股份有限公司(以下简称以岭药业)是一家位于河北石家庄市的中成药研发、生产和销售企业,董事长吴相君兼任总经理,从成立伊始,以岭药业便一直秉承“高品质,前瞻研发”的宗旨,发展壮大。从2012年开始,以岭药业的未分配利润便急剧增长,从2011年的1.17亿元到今年的5.99亿元,预计2020年进一步增长。以岭药业做出了引人注目的业绩,其经营成功大大超出市场预期,给投资者带来可观的回报,未来还将进一步拓展市场,挖掘不足以满足市场需求的产品和服务,实现新的增长点。总的来说,以岭药业的未来展望令人信心满满。

石家庄以岭药业股份有限公司 (002603)是一家主要从事中成药研发、生产和销售的石家庄企业,产品服务遍布全国并出口世界各地。,"002603","以岭药业","Yiling Pharmaceutical","吴相君","吴相君","ESG 300","国证A指","巨潮中盘","深成指R","深市精选","深证100","深证100R","深证300","深证成指","深证新兴","中创100","中小100","中小300","中小新兴","数据可视化","上市公司财报","数据分析","极坐标图","花火数图","图表"

我也要免费做极坐标图

石家庄以岭药业股份有限公司 (002603)是一家主要从事中成药研发、生产和销售的石家庄企业,产品服务遍布全国并出口世界各地。,"002603","以岭药业","Yiling Pharmaceutical","吴相君","吴相君","ESG 300","国证A指","巨潮中盘","深成指R","深市精选","深证100","深证100R","深证300","深证成指","深证新兴","中创100","中小100","中小300","中小新兴","数据可视化","上市公司财报","数据分析","极坐标图","花火数图","图表"

我也要免费做极坐标图

报表日期未分配利润
202212315,989,178,389.49
202112314,306,249,874.08
202012314,324,369,991.29
201912313,483,093,598.46
201812313,071,722,195.81
201712312,650,073,440.71
201612312,290,030,492.63
201512311,902,060,686.21
201412311,562,931,271.80
201312311,293,064,298.16
201212311,117,911,788.98
20111231990,869,753.15
20101231571,905,497.34
20091231564,560,166.56
20081231267,470,485.33

我也要免费做极坐标图